TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, cilt.26, sa.1, ss.48-54, 2017 (Hakemli Dergi)
OBJECTIVE: Chronic antibody mediated rejection (CAMR) is a major therapeutic challenge for achieving long-term graft survival; treatment options are limited to several anti-humoral interventions.